Ticagrelor

• TicAgreLor versus placebo to prevent cerebral ISCHemia in anEuRysmal low grade SAH A double blinded randomised controlled study Pending
  2023-509795-42-00 Phase III 1 country Centre Hospitalier Universitaire De Toulouse
• ARMYDA TICA-MI study Pending
  2024-511944-18-01 Phase IV 1 country Azienda Ospedaliero-Universitaria Maggiore Della Carita
• COATS (genetic Clopidogrel response testing to finetune the antithrombotic regimen in (D)OAC Treated patients undergoing PCI) Study Pending
  2024-512350-17-01 Phase IV 1 country Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
• VerifyNow to Optimise Platelet Inhibition in Coronary Acute Syndrome (VERONICA) Recruiting
  2024-512436-29-00 Phase III/IV 1 country Fundacion Epic
• Safety and efficacy of very short dual antiplatelet therapy followed by P2Y12 inhibitor monotherapy in older patients undergoing percutaneou… Recruiting
  2023-507545-28-00 Phase IV 1 country Centre Hospitalier Universitaire De Caen Normandie
• Treatment with a single drug that prevents blood clot formation followed by an anticoagulant drug in patients with irregular heartbeat who h… Recruiting
  2023-509717-36-00 Phase III 7 countries Insel Gruppe AG
• The One-Month DAPT with Ticagrelor In CABG PatieNts Trial (ODIN) Recruiting
  2023-506613-22-00 Phase III 3 countries Weill Medical College Of Cornell University
• Drug-Coated Balloon in Anticoagulated and Bleeding Risk Patients Undergoing PCI (DEBATE) Recruiting
  2023-504340-34-01 Phase IV 3 countries Wellbeing Services County Of North Karelia Siun Sote
• Personalized, CT-guided antithrombotic therapy versus lifelong single antiplatelet therapy to reduce thromboembolic and bleeding events in n… Recruiting
  2023-504637-42-01 Phase IV 5 countries St Antonius Hospital
• Early reduction of antiplatelet therapy in patients with Acute Coronary Syndrome treated with stent implantation and at high risk of bleedin… Recruiting
  2023-509868-20-00 Phase III 1 country Azienda Ospedaliera Universitaria Gaetano Martino Messina
• Preventing formation of blood clots due to atrial fibrillation, a cardiac arrhythmia that first occurred after coronary bypass surgery, with… Recruiting
  2024-515924-35-00 Phase IV 1 country Icahn School Of Medicine At Mount Sinai
• WOEST-3 Recruiting
  2022-502140-13-00 Phase IV 4 countries St Antonius Hospital
• The Dan-DAPT trial Recruiting
  2022-500125-32-00 Phase IV 1 country Rigshospitalet
• Single antiplatelet treatment with Ticagrelor or Aspirin after Transcatheter Aortic Valve Implantation: multicenter randomized clinical tria… Recruiting
  2023-509290-22-00 Phase IV 3 countries Fundacion Biomedica Galicia Sur
• Study to evaluate reduced antiplatelet therapy after angiolite stent implantation in patients with coronary artery disease Ended
  2023-507015-35-00 Phase III 3 countries Ivascular S.L.
• Randomized clinical trial assessing the value of Beta-Blockers and Antiplatelet Agents in patients with Spontaneous Coronary Artery Dissecti… Ended
  2024-516039-28-00 Phase IV 1 country Spanish Society Of Cardiology
• Dual antiplatelet therapy with ticagrelor and acetylsalicylic acid (ASA) vs. ASA only after isolated coronary artery bypass grafting in pati… Ended
  2023-508551-40-00 Phase IV 5 countries Vaestra Goetalandsregionen
• Individualized anti-platelet therapy in patients with stable coronary artery disease undergoing stenting Ended
  2023-504078-39-01 Phase IV 1 country St Antonius Hospital
• A large global trial to evaluate the efficacy and safety of milvexian in reducing recurrent cardiovascular events in patients after a heart … Ended
  2022-501418-69-00 Phase III 20 countries Janssen - Cilag International
• Evaluation of safety i efficacy de-escalation antiplatelet strategies in acute coronary syndrome. Ended
  2024-518090-34-00 Phase III 1 country Nicolaus Copernicus University
• Escalated single Platelet Inhibition for one month plus Direct oral anticoagulation in patients with Atrial fibrillation and acUte coRonary … Ended
  2024-512727-36-00 Phase IV 2 countries Klinikum der Universitaet Muenchen AöR
• Ticagrelor monotherapy after coronary stenting in patients with acute myocardial infarction - A prospective single-centre, single-arm phase … Ended
  2024-514224-17-00 Phase II 1 country Vaestra Goetalandsregionen
• Dual Antithrombotic Therapy with Dabigatran and Ticagrelor in Patients with Acute Coronary Syndrome and Non-valvular Atrial Fibrillation Und… Ended
  2024-515056-20-00 Phase III 1 country Medical University Of Gdansk
• A study designed to evaluate a modified Anti-Platelet Therapy (drugs that preventblood platelets from clotting) after implantation of a Fire… Ended
  2024-519854-35-00 Phase IV 3 countries SORIN CRM SAS (Microport CRM)

Showing 1–24 of 25 trials